Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
d-Penicillamine Chelation in Lead-Poisoned Children
NCT00552630Phase 3Withdrawn
- Sponsor
- Food and Drug Administration
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of penicillamine in lead poisoning, sponsored by Food and Drug Administration. Planned start Sep 2007; status: withdrawn.
02
Drugs
penicillamine
03
Conditions
lead poisoning
Beyond the preview
Go deeper on NCT00552630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00552630.